Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026

October 29, 2026 The Manager (CRD) The Manager- Listing Department The BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/l, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East) Mumbai- 400001 Mumbai - 400 051 Scrip Code: 530117 Symbol: PRIVISCL DearSir/Madam, Sub: Outcome of the Board Meeting held today i.e. October 29, 2026, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulations 30 and 33 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Thursday, October 29, 2026, have inter alia, considered and approved: 1. the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. In terms of the provisions of Regulation 33 of the SEBI Listing Regulations, we hereby enclose the following as Annexure - I: a. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026; b. Statement of Assets and Liabilities as on September 30, 2026; c. Cash Flow Statement for the half year ended September 30,2026; and d. Limited Review Report on the said Unaudited Standalone and Consolidated Financial Results issued by the Statutory Auditors of the Company. 2. declaration of a first interim dividend of Rs. 5 per Equity Share of face value of Rs. 10 each of the Company, for the financial year 2026-27. The Company has fixed November 04,2026 as the "Record Date" for determining the eligibility of equity shareholders of the Company for payment of first interim dividend on equity shares. The payment of the first interim dividend shall be made on or before November 25, 2026. 3. the investment limit of Rs. 2,97,00,000 (Rupees Two Core Ninety-Seven Lakhs Only), in one or more tranches in M/s Opera Dwarka Projects Private Limited for Wind Solar Hybrid project at Gujarat for Unit VI. The Company shall update the exchanges and make necessary disclosure as ^:^ per regulation 30 of SEBI Listing Regulations at the time of execution of definitive agreements; >'''~^S;^> and actual investment(s). REGO. OF;:iCE 0 PRIV1 SPECIALITY CHEMICALS LIMITED ^2^ .^ 1509001:2015 18014001:2015 18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station, BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045 Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | CIN:L15140MH1985PLC286828 The meeting of the Board of Directors commenced at 11:45 a.m. and concluded at 12:55 p.m. The above disclosure shall also be made available on the website of the Company at www.privi.com. Kindly take the above on record and oblige. Thanking You, Yours Sincerely, For Privi Speciality Chemicals Limited Ashwini Saumil Shah \^^>- '\ Company Secretary and Compliance OWcer^SbS' Membership No.: A58378 End:As above PRIVI SPECIALITY CHEMICALS LIMITED 1309001:2015 18014001:2015 18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station, BUREAU VER1TAS Navi Mumbai - 400 710. India | Tel. : +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045 Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | GIN: L15140MH1985PLC286828 B S R& Co. LLP 14th Floor, Central B Wing and North C Wing Nesco IT Park 4, Nesco Center Western Express Highway Chartered Accountants Goregaon (East), Mumbai - 400 063, India Telephone: +91 (22) 6257 1000 Fax:+91 (22)6257 1010 Limited Review Report on unaudited standalone financial results of Privi Speciality Chemicals Limited for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Privi Speciality Chemicals Limited 1. We have reviewed the accompanying Statement of unaudited standalone financial results of Privi Speciality Chemicals Limited (hereinafter referred to as "the Company") for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 ("the Statement"). 2. This Statement, which is the responsibility of the Company's management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. ForB S R & Co. LLP Chartered Accountants Firm's Registration No.:101248W/W-100022 Partner Mumbai Membership No.: 105317 29 October 2026 UDIN:26105317RUYJYJ9804 Registered Office: B SR &Co. (a partnership firm with Registration No. BA61223) converted into B S R& Co. LLP (a 14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Limited Liability Partnership with LLP Registration No. AAB-8181) with effect from October 14. 2013 Center, Western Express Highway, Goregaon (East), Mumbai - 400063 Page 1 of 1 Privi Speciality Chemicals Limited Regd. Office : Privi House, A-71,TTC Industrial Area,Thane Belapur Road,Kopar Khairane, Navi Mumbai - 400 710,India Email: investors@privi.co.in Phone : +91 22 33043500 / 33043600 Fax : +91 22 27783049 Website : www.privi.com CIN : L1S140MH1985PLC286828 PRIVI Unaudited standalone statement of assets and liabilities as at September 30, 2026 ( Rs. In Lakhs) As at September 30, 2026 | As at March 31, 2026 Particulars Unaudited Audited Assets Non-current assets Property, plant and equipment 89,563.19 95,848.10 Capital work-in-progress 36,160.04 21,740.42 Right of use assets 4,738.62 4,035.95 Other Intangible assets 681.87 641.50 Intangible assets under development 2,061.82 1,611.82 Financial assets Investments 8,747.62 8,727.93 Other financial assets 2,084.63 1,903.44 Income tax assets (net) 1,970.49 656.33 Other non-current asset [Showing first 8,000 characters — download PDF for full document]